ESR1 and breast neoplasm: Interestingly, CAMP expression is closely correlated with that of epidermal growth factor receptor 2 (HER2) and with the presence of lymph node metastases in estrogen receptor (ER) + breast tumors, suggesting a prometastatic role for CAMP in breast malignancy [14].